New announcement. Learn more

ResearchHistoryTeamAdvocacyDCSS auditBoardIn the NewsNew medicationType 2 diabetesPublicationCommunityPHARMACHealth promotionEquityHealth & WellnessAnnual Activity ReportBrandingDcssNZSSDPrimary careStaffConferenceEthnic disparitiesGardens4healthSummit2023DataEducationHealthy eatingMedicationDPTHealth educationKidney diseaseLets Beat DiabetesSchoolsAccessCMDHBCovid-19Lifestyle ProgrammeNutritionThrowbackBariatric projectExerciseGDMGetwize2healthInequityNurse PractitionerOtaraPhDPrecision medicinePreventionPVAResourcesSouth AucklandTrulicityType 1 diabetesWDDWhakataukiWORTH studyYouth2006201020212022AdolescentBariatric SurgeryCampaignCelebrationDebateEpidemiologyGardeningGestational DiabetesHealthy environmentKaumatuaMedicationsMyLifeMattersObesityPatient perspectivePatient Voice AotearoaPre-DiabetesProgrammeSafetyWebsitesWorld Diabetes Day20052007AimBarriersCardiovascular diseaseCGMCMHComplicationsDiabetes resourcesEthicsEventFairnessG4HHeart failureIGTImpaired Glucose ToleranceKate SmallmanLBDMedical directorMiddlemoreNZMJOutcomesPerformancePhysical activityPilotPostersPregnancyPublic healthQualitativeQuality AuditReportSADPSocioeconomic disparitiesTalanoa approachTe Whatu OraThank youThe renew roomTikanga MāoriTrust DeedVisionVLCDWorkplaces19962008200920152016201820192020AdolescentsANZMOSSAtrial FibrillationAucklandAustraliaAwarenessBlood pressureBreast feedingBudgetCanadaCapacity buildingCholesterolChristmasCo-designComicConsultationContinuous Glucose MonotiringCook'n KiwiCounties ManukauDiabetes EducatorDirectoryDisparityDoor-To-Door studyDry weather gardeningDulaglutideEnablersExcellence awardEye ScreeningFootcareGoutGreen Lip MusselsHolidayHyperglycaemiaIFGInformation sheetsInsulinJAHAJardianceJournal of American Heart AssociationMātanga TapuhiMedirayMITMortalityMotivationMy Life MattersNoMoreFearOffice hoursOlder agegroupOrganicOverweightPassport studyPetitionPhotographsPlanningPolicyPost covidProfessional developmentProvidersRandomised control trialRCTRegistryRichard cooperRoadshowRocketsparkScreeningSouth Auckland Diabetes ProjectSpecial KSportsStakeholdersStocktakeStrategySugarbustersSummerTe Tiriti O WaitangiTongaTrain the TrainerTriathlonValuesVegetablesWater conservationWhitioraWomenWorkplace exercise
TAGS

In the News:

Professor David Simmons talks about new research just published from the DCSS data gathered Auckland over a 20 year period from Primary care.  See here for more information on the data source and here for the journal article. “It’s very clear from the data that leaving things as they are isn’t going to work.”  "Pharmac needs to fund medicines such as Empagliflozin and Dulaglutide to help treat people with diabetes".  “We can’t have people at the bottom of the cliff not getting access to these drugs, it’s inequitable and it’s discriminatory. This is something that’s needed now,” he said.

Diabetes Foundation Aotearoa chairman Dr John Baker is in full agreement, he has said he believes that the drugs currently being prescribed for type 2 diabetes in New Zealand are being described as "Third World treatments".  His view is that the study "highlights the need for Pharmac to fund Empagliflozin and Dulaglutide as they can add years to a patient’s life and prevent their progression to end stage kidney disease by up to 15 years".

National Urban Māori Authority chairwoman Tureiti Moxon notes "We've got to turn this around". 

https://www.stuff.co.nz/national/politics/local-democracy-reporting/300134521/the-lancet-publishes-major-study-on-south-aucklands-diabetes-epidemic?fbclid=IwAR0m4Oparr30i7gtoXxtLwdtLaCjaGh_nDGEq2O01XW5Jb6aEziHfVtE5c0